These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 29346191)

  • 1. The Four Corners Sign: A Specific Imaging Feature in Differentiating Systemic Sclerosis-related Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.
    Walkoff L; White DB; Chung JH; Asante D; Cox CW
    J Thorac Imaging; 2018 May; 33(3):197-203. PubMed ID: 29346191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse Pulmonary Ossification on High-Resolution Computed Tomography in Idiopathic Pulmonary Fibrosis, Systemic Sclerosis-Related Interstitial Lung Disease, and Chronic Hypersensitivity Pneumonitis: A Comparative Study.
    Walkoff L; Dixit AS; Ryu JH; Chung JH; Cox CW
    J Comput Assist Tomogr; 2020; 44(5):667-672. PubMed ID: 32842066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiographic fibrosis score predicts survival in systemic sclerosis-associated interstitial lung disease.
    Takei R; Arita M; Kumagai S; Ito Y; Tokioka F; Koyama T; Saito R; Nishimura K; Tokumasu H; Ishida T
    Respirology; 2018 Apr; 23(4):385-391. PubMed ID: 28925574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
    Desai SR; Veeraraghavan S; Hansell DM; Nikolakopolou A; Goh NS; Nicholson AG; Colby TV; Denton CP; Black CM; du Bois RM; Wells AU
    Radiology; 2004 Aug; 232(2):560-7. PubMed ID: 15286324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.
    Chung JH; Cox CW; Montner SM; Adegunsoye A; Oldham JM; Husain AN; Vij R; Noth I; Lynch DA; Strek ME
    AJR Am J Roentgenol; 2018 Feb; 210(2):307-313. PubMed ID: 29140119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease.
    Valenzi E; Tabib T; Papazoglou A; Sembrat J; Trejo Bittar HE; Rojas M; Lafyatis R
    Front Immunol; 2021; 12():595811. PubMed ID: 33859634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease.
    Chung JH; Walker CM; Hobbs S
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32744514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound B-lines in the evaluation of interstitial lung disease in patients with systemic sclerosis: Cut-off point definition for the presence of significant pulmonary fibrosis.
    Tardella M; Di Carlo M; Carotti M; Filippucci E; Grassi W; Salaffi F
    Medicine (Baltimore); 2018 May; 97(18):e0566. PubMed ID: 29718851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.
    Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ
    Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.
    Kennedy B; Branagan P; Moloney F; Haroon M; O'Connell OJ; O'Connor TM; O'Regan K; Harney S; Henry MT
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):228-36. PubMed ID: 26422568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease.
    Lee SC; Huang CH; Oyang YJ; Huang HC; Juan HF
    J Transl Med; 2024 Jun; 22(1):600. PubMed ID: 38937794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19.
    Orlandi M; Landini N; Sambataro G; Nardi C; Tofani L; Bruni C; Bellando-Randone S; Blagojevic J; Melchiorre D; Hughes M; Denton CP; Luppi F; Ruaro B; Della Casa F; Rossi FW; De Luca G; Campochiaro C; Spinicci M; Zammarchi L; Tomassetti S; Caminati A; Cavigli E; Albanesi M; Melchiorre F; Palmucci S; Vegni V; Guiducci S; Moggi-Pignone A; Allanore Y; Bartoloni A; Confalonieri M; Dagna L; DeCobelli F; dePaulis A; Harari S; Khanna D; Kuwana M; Taliani G; Lavorini F; Miele V; Morana G; Pesci A; Vancheri C; Colagrande S; Matucci-Cerinic M
    Rheumatology (Oxford); 2022 Apr; 61(4):1600-1609. PubMed ID: 34320649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hiatal hernia on thoracic computed tomography in pulmonary fibrosis.
    Tossier C; Dupin C; Plantier L; Leger J; Flament T; Favelle O; Lecomte T; Diot P; Marchand-Adam S
    Eur Respir J; 2016 Sep; 48(3):833-42. PubMed ID: 27174889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue disease.
    Yamakawa H; Ogura T; Sato S; Nishizawa T; Kawabe R; Oba T; Kato A; Horikoshi M; Akasaka K; Amano M; Kuwano K; Sasaki H; Baba T; Matsushima H
    Respir Med; 2020 Oct; 172():106125. PubMed ID: 32911135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).
    Khedoe P; Marges E; Hiemstra P; Ninaber M; Geelhoed M
    Front Immunol; 2020; 11():1990. PubMed ID: 33013852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for interstitial lung disease in systemic sclerosis: performance of high-resolution CT with limited number of slices: a prospective study.
    Frauenfelder T; Winklehner A; Nguyen TD; Dobrota R; Baumueller S; Maurer B; Distler O
    Ann Rheum Dis; 2014 Dec; 73(12):2069-73. PubMed ID: 25269829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study.
    Richardson C; Agrawal R; Lee J; Almagor O; Nelson R; Varga J; Cuttica MJ; Dematte JD; Chang RW; Hinchcliff ME
    Semin Arthritis Rheum; 2016 Aug; 46(1):109-14. PubMed ID: 27033049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
    Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
    Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.
    Khanna D; Tashkin DP; Denton CP; Renzoni EA; Desai SR; Varga J
    Am J Respir Crit Care Med; 2020 Mar; 201(6):650-660. PubMed ID: 31841044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling.
    Salisbury ML; Xia M; Murray S; Bartholmai BJ; Kazerooni EA; Meldrum CA; Martinez FJ; Flaherty KR
    Respir Med; 2016 Sep; 118():88-95. PubMed ID: 27578476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.